Pramipexole Dihydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers, 24 USDMF, 18 CEP/COS, 2 JDMF, 17 EU WC, 10 KDMF, 12 NDC API, 29 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

8 Suppliers

8 Suppliers

DOSSIERs // Finished Dosage Forms

695 Dossiers, 181 FDA Orange Book, 345 Europe, 34 Canada, 37 Australia, 29 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 23 Roquette, 18 Kerry, 16 SPI Pharma, 16 Corel Pharma Chem, 11 Microlex e.U, 10 BASF, 9 Sigachi Industries, 9 Gangwal Healthcare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Seppic, 7 Gangwal Chemicals, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 5 Boai NKY Pharmaceuticals Ltd, 5 Lubrizol Life Science Health, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Ulanqab Kema New Material, 2 Pharmatrans-Sanaq, 2 DKSH, 2 DFE Pharma, 2 The Dow Chemical Company, 2 Prachin Chemical, 2 Vasa Pharmachem, 2 Rochem International Inc, 1 Pfanstiehl, 1 Pharm-RX Chemical, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Nanjing Well Pharmaceutical, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Qualicaps, 1 Shanghai Welltone Material Technology Co., Ltd, 1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 32 Thickeners and Stabilizers, 31 Direct Compression, 30 Controlled & Modified Release, 22 Taste Masking, 21 Solubilizers, 18 Granulation, 15 Chewable & Orodispersible Aids, 14 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Disintegrants & Superdisintegrants, 9 Film Formers & Plasticizers, 7 Topical, 7 API Stability Enhancers, 6 Parenteral, 5 Empty Capsules, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Rheology Modifiers, 2 Coloring Agents

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 237 Finished Drug Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS

14 US Patents, 17 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 BioAnalytical Methods, 3 EDQM Standards, 3 USP Standards, 16 Other Ref. Standards

DIGITAL CONTENT

19 News

19 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing Pramipexole Dihydrochloride. Original Data : Therapeutic Goods Administration Website

Pramipexole Dihydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers

24 USDMF

18 CEP/COS

2 JDMF

17 EU WC

10 KDMF

12 NDC API

29 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

8 Suppliers

DOSSIERs // Finished Dosage Forms

695 Dossiers

181 FDA Orange Book

345 Europe

34 Canada

37 Australia

29 South Africa

69 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

23 Roquette

18 Kerry

16 SPI Pharma

16 Corel Pharma Chem

11 Microlex e.U

10 BASF

9 Sigachi Industries

9 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Seppic

7 Gangwal Chemicals

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

5 Boai NKY Pharmaceuticals Ltd

5 Lubrizol Life Science Health

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

3 Kima Chemical

3 Ulanqab Kema New Material

2 Pharmatrans-Sanaq

2 DKSH

2 DFE Pharma

2 The Dow Chemical Company

2 Prachin Chemical

2 Vasa Pharmachem

2 Rochem International Inc

1 Pfanstiehl

1 Pharm-RX Chemical

1 Aeon Procare

1 Qianhao Chemical (Hebei) Co., Ltd

1 Nanjing Well Pharmaceutical

1 Shijiazhuang Huaxu Pharmaceutical

1 Qualicaps

1 Shanghai Welltone Material Technology Co., Ltd

1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders

43 Coating Systems & Additives

32 Thickeners and Stabilizers

31 Direct Compression

TABLET;ORAL - 0.125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 1.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons